Human Laboratory Models of Cannabis Use Disorder-Reference-Cited by-同舟云学术

Human Laboratory Models of Cannabis Use Disorder

Published:2018-11-25 Issue: Volume: Page:75-84
ISSN:
Container-title:Cannabis Use Disorders
language:
Short-container-title:

Author:

Arout Caroline A.,Herrmann Evan,Haney Margaret

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-90365-1_9

Reference94 articles.

1. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011;119:123–9.

2. Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7:249–64.

3. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101–6.

4. Association A. P. The Diagnostic and statistical manual of mental disorders: DSM 5: BookpointUS; 2013.

5. Bigelow G, Griffiths R, Liebson I. Experimental models for the modification of human drug self-administration: methodological developments in the study of ethanol self-administration by alcoholics. Fed Proc. 1975;34:1785–92.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of cyclooxygenase‐2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers;Addiction Biology;2022-05-25

2. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings;Journal of Neurochemistry;2021-05-16

3. Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research;Frontiers in Psychiatry;2021-02-25

4. 5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers;Addiction Biology;2021-01-03